Successful eradication of acquired factor-VIII-inhibitor using single low-dose rituximab

Haematologica

Volumn 95, Issue 3, 2010, Pages 521-522

  Wermke, Martin ^a   Von Bonin, Malte ^a   Gehrisch, Siegmund ^a   Siegert, Gabriele ^a   Ehninger, Gerhard ^a   Platzbecker, Uwe ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Cyclophosphamide; Hemophilia A; Partial thromboplastin time (aPTT)

Indexed keywords

BLOOD CLOTTING FACTOR 8 INHIBITOR; PREDNISOLONE; RITUXIMAB;

AGED; B LYMPHOCYTE; CASE REPORT; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG TOLERABILITY; ERYTHROCYTE CONCENTRATE; FOLLOW UP; HEMOPHILIA A; HUMAN; LETTER; LOW DRUG DOSE; LYMPHOCYTE DEPLETION; MALE; RECURRENT DISEASE; SINGLE DRUG DOSE; WOUND HEALING IMPAIRMENT;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; FACTOR VIII; HEMOPHILIA A; HUMANS; MALE; TREATMENT OUTCOME;

EID: 77949672959     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.017749     Document Type: Letter

References (8)

1. Huth-Kuhne A, Baudo F, Collins P, Ingerslev J, Kessler CM, Levesque H, et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica. 2009;94(4):566-75.
2. Mannucci PM, Peyvandi F. Autoimmune hemophilia at rescue. Haematologica. 2009;94(4):459-61.
3. Huth-Kuhne A. Cautions and caveats to the treatment of acquired hemophilia A. Haematologica. 2009;94(8):1181-2.
4. Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood. 2007;109(5):1870-7.
5. Green D, Rademaker AW, Briet E. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor-VII autoantibodies. Thrombosis and Haemostas. 1993;70(5):753-7.
6. Franchini M. Rituximab in the treatment of adult acquired hemophilia A: A systematic review. Crit Rev Oncol Hematology. 2007;63(1):47-52.
7. Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. 2009;113(20):4834-40.
8. Von Bonin M, Oelschlagel U, Radke J, Stewart M, Ehninger G, Bornhauser M, et al. Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab. Transplantation. 2008;86(6):875-9.